Silver Book

Mitral Valve Disease

Publications

Categories

10 Matching Facts

Search matching Facts:
No results to display
    • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.
       
    • The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.
       
    • Pulmonary hypertension is a complication in at least 23% of patients with significant mitral regurgitation due to flail leaflet, and approximately doubles the risk of death and heart failure after diagnosis.
       
    • Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.
       
    • Hospital Discharges from Heart Valve Disease in 2010*
       
    • Mitral valve disease is present in 5.1% of the population ages 65 and older.
       
    • Survival rates of patients ages 65-75 with valve repair and replacement
       
    •  
    • Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
       
    • Mitral valve disease costs
      Mitral valve disease (symptomatic and asymptomatic) costs the U.S. at least $13.2 billion in direct healthcare expenditures each year.